Loading clinical trials...
Loading clinical trials...
With this design, this study hypothesizes that; (i) ICG-PDT would produce superior clinical, microbiological, and immune-inflammatory outcomes as compared to RSD and (ii) ICG-PDT would produce equal e...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
King Saud University
NCT06613854 · Type 2 Diabetes Mellitus (T2DM)
NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus
NCT07403604 · Hyperinsulinemia, Insulin Resistance, and more
NCT06278207 · Chronic Kidney Disease, Type 2 Diabetes Mellitus
NCT06810635 · Type 2 Diabetes Mellitus (T2DM)
College of Applied Medical Sciences, King Saud University
Riyadh
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions